The "Affordable Insulin Now Act" is a federal bill aimed at reducing the cost of insulin for Americans. The main provisions of the bill include capping the out-of-pocket expenses for insulin at $35 per month for individuals with health insurance, expanding access to affordable insulin through government programs, and increasing transparency in pricing by pharmaceutical companies. This legislation seeks to make life-saving insulin more affordable and accessible to those who rely on it, potentially easing financial burdens and improving health outcomes for individuals with diabetes.
2023-03-09: Introduced in House
2023-03-09: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2023-03-17: Referred to the Subcommittee on Health.
Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.
No Reviews found ..